Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FORKiDs: Immunomodulatory Therapy Criteria in Kawasaki Disease
jRCT2031260219Recruiting
- Sponsor
- Hamada Hiromichi
- Start
- Jul 2026
- Modality
- Small Molecules, Peptides
- Countries
- 2
01
Overview
Single-arm trial of cyclosporine in Kawasaki disease (KD), sponsored by Hamada Hiromichi. Started Jul 2026; status: recruiting.
02
Drugs
cyclosporine
03
Conditions
Kawasaki disease (KD)
Beyond the preview
Go deeper on jRCT2031260219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031260219.